HM PharmaConsultancy

How AI can help find new uses for the drugs we have icthealth.org/news/how-ai-ca…

Hermann Mucke will present "RepoScope: An AI-supported database to build a navigable network of drug repurposing prior art" at #RExPO25. A first for a broad audience! - drugrepocentral.scienceopen.com/hosted-documen…

New journal at #ScienceOpen: Network and Systems Medicine drugrepocentral.scienceopen.com/collection/Net… The first papers: drugrepocentral.scienceopen.com/hosted-documen…) and drugrepocentral.scienceopen.com/hosted-documen…

'International Drug Repurposing Patent Landscape, Part 3: Chronic Neurodegenerative Diseases 2010-2024' an article on #ScienceOpen: drugrepocentral.scienceopen.com/document?vid=c…

International Drug Repurposing Patent Landscape, Part 3: Chronic Neurodegenerative Diseases 2010-2024 DrugRxiv DOI: doi.org/10.58647/DRUGA…

@cdsouthan All show some processed data. Open Data as per definition is something you will hardly find in a patent application, although the assignee has to show the examiner the raw data on request.

Interesting compilation @hmpharmacon but are their open data to support RW therapeutic efficacy for any of these?

🎄With our Christmas Newsletter🌟, we wish you a wonderful holiday season & a happy + healthy new year: mailchi.mp/concentris/ope… See you again in 2025😊 #ProposalWriting #ScienceCommunication #ProjectManagement #ConferenceServices @HorizonEU @ERC_Research @BMBF_Bund @dfg_public

"International #DrugRepurposing #Patent Landscaping, Part 2: The Early Months of #Covid19 drugrepocentral.scienceopen.com/hosted-documen…

What we love about our General Assemblies: We get to receive quality #feedback, from our Scientific and Ethical Advisory Board Members Dr. #HermannMucke of @hmpharmacon, also on behalf of Prof. #DominiqueValla,

'International Drug Repurposing Patent Landscaping, Part 2: The Early Months of Covid-19' an article on #ScienceOpen: scienceopen.com/document?vid=6…

Patent highlights February–March 2024 tandfonline.com/doi/full/10.10…

Next up: Work package presentations! 🧪 Selection and validation of combinatorial therapies using #preclinical rat models and set-up of #biomarkers of outcome and of companion diagnostics in patients’ samples. Presented by @UschnerFrank #ACLF @MEDB_LAB @JonelTrebicka

@Decision4Liver @UschnerFrank @MEDB_LAB @JonelTrebicka

The value of ‘wasting time’ on deep thinking is often overlooked in a scientific ecosystem increasingly tainted by Wall Street’s productivity mindset. nature.com/articles/d4158…

In the inaugural issue of the new #ScienceOpen OA journal, #DrugRepurposing: #Patent Landscaping for #rarediseases 2010–2023 drugrepocentral.scienceopen.com/hosted-documen…

⭐️New Editor Spotlight on Hermann Mucke⭐️ Founder and CEO of @hmpharmacon, and a pivotal contributor to @REPO4EU, Mucke is a pioneer in #DrugRepurposing. Read more in our latest blog-post 👇 blog.scienceopen.com/2024/07/editor…

@SDawsonBerlin @hhhwschmidt 💊 'Drug Repurposing: Then, Now, and in the Future' is an Honorary Lecture by Hermann Mucke of @hmpharmacon from Systems Medicine, AI, and Drug Repurposing (RExPO23), detailing the history and future potential of drug repurposing. drugrepocentral.scienceopen.com/hosted-documen…

#drugrepurposing #patent applications January–March 2024 liebertpub.com/doi/10.1089/ad…

Just finished the final review with the EU Commission's #HADEA for our concluded #H2020 #drugrepurposing project, REPO-TRIAL (repo-trial.eu). We have already made a smooth transition to the much larger #HorizonEurope follow-up project, #REPO4EU (repo4.eu)

One for the tractable proteome aficionados. Selects from the human Swiss-Prot cross-refs for chemistry (except Pharos under Miscellaneous) Interesting but also slightly puzzling aspects (e.g. 47 Tchem not in ChEMBL) Note 132 BindingDB uniques may include patent-only targets